Thirty-Day Outcomes of the Enterprise Stent in Treating Hypoperfusion of Symptomatic Intracranial Stenosis. Huang CM, Hong YF, Xing SH, Xu K, et al. World Neurosurg 2019;129:e429-e435.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Huang CM, Hong YF, Xing SH, Xu K, et al. Thirty-Day Outcomes of the Enterprise Stent in Treating Hypoperfusion of Symptomatic Intracranial Stenosis. World Neurosurg 2019;129:e429-e435.
PMID: 31150855